Beleodaq and Tafamidis, Tafamidis Meglumine
Determining the interaction of Beleodaq and Tafamidis, Tafamidis Meglumine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Coadministration with inhibitors of UGT1A1 may increase the plasma concentrations of belinostat, which is primarily (80% to 90%) metabolized by UGT1A1-mediated glucuronidation. MANAGEMENT: Concomitant use of belinostat with potent UGT1A1 inhibitors such as atazanavir should generally be avoided. Caution is advised when used with other agents that may also inhibit UGT1A1 such as nilotinib, pazopanib, regorafenib and sorafenib. Patients should be monitored closely for potentially increased adverse effects such as nausea, vomiting, diarrhea, thrombocytopenia, leukopenia (neutropenia and lymphopenia), anemia, infection, and hepatotoxicity. References "Product Information. Beleodaq (belinostat)." Spectrum Pharmaceuticals Inc, Irvine, CA.
Professional:GENERALLY AVOID: Coadministration with inhibitors of UGT1A1 may increase the plasma concentrations of belinostat, which is primarily (80% to 90%) metabolized by UGT1A1-mediated glucuronidation.
MANAGEMENT: Concomitant use of belinostat with potent UGT1A1 inhibitors such as atazanavir should generally be avoided. Caution is advised when used with other agents that may also inhibit UGT1A1 such as nilotinib, pazopanib, regorafenib and sorafenib. Patients should be monitored closely for potentially increased adverse effects such as nausea, vomiting, diarrhea, thrombocytopenia, leukopenia (neutropenia and lymphopenia), anemia, infection, and hepatotoxicity.
- "Product Information. Beleodaq (belinostat)." Spectrum Pharmaceuticals Inc, Irvine, CA.
Generic Name: tafamidis
Brand name: Vyndamax, Vyndaqel
Synonyms: Tafamidis
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Beleodaq-Tafenoquine
- Beleodaq-Tafenoquine (Malaria Prevention)
- Beleodaq-Tafenoquine (Prevention of Malaria Relapse)
- Beleodaq-Tafenoquine Succinate (Arakoda)
- Beleodaq-Tafenoquine Succinate (Krintafel)
- Beleodaq-Tafinlar
- Tafamidis, Tafamidis Meglumine-Beleodaq Injection
- Tafamidis, Tafamidis Meglumine-Belimumab
- Tafamidis, Tafamidis Meglumine-Belimumab Auto-Injectors and Prefilled Syringes
- Tafamidis, Tafamidis Meglumine-Belimumab Intravenous
- Tafamidis, Tafamidis Meglumine-Belimumab Vials
- Tafamidis, Tafamidis Meglumine-Belinostat